image
Agree Realty Corporation ADC
Real Estate - REIT - Retail - NYSE - US
Watchlist
$ 71.38
-4.14 %
$ 7.66 B
Market Cap
40.1
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ADC stock under the worst case scenario is HIDDEN Compared to the current market price of 71.4 USD, Agree Realty Corporation is HIDDEN

ADC Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ADC stock under the base case scenario is HIDDEN Compared to the current market price of 71.4 USD, Agree Realty Corporation is HIDDEN

ADC Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ADC stock under the best case scenario is HIDDEN Compared to the current market price of 71.4 USD, Agree Realty Corporation is HIDDEN

ADC Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart ADC

image
1M -6%
6M -5%
1Y 32%
3Y 14.0%
5Y 40%
All
$78.0$78.0$77.0$77.0$76.0$76.0$75.0$75.0$74.0$74.0$73.0$73.0$72.0$72.0$71.0$71.0$70.0$70.0$69.0$69.0$68.0$68.0$67.0$67.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
617 M REVENUE
14.81%
Growth Rates
1Year 14.81%
3Years 19.28%
5Years 26.91%
7Years 26.88%
10Years 27.69%
302 M OPERATING INCOME
18.81%
Growth Rates
1Year 18.81%
3Years 16.68%
5Years 24.49%
7Years 25.28%
10Years 26.91%
190 M NET INCOME
11.31%
Growth Rates
1Year 11.31%
3Years 15.60%
5Years 18.64%
7Years 18.23%
10Years 25.94%
432 M OPERATING CASH FLOW
10.31%
Growth Rates
1Year 10.31%
3Years 20.59%
5Years 27.80%
7Years 26.75%
10Years 28.53%
-885 M INVESTING CASH FLOW
30.56%
Growth Rates
1Year 30.56%
3Years 13.89%
5Years -5.81%
7Years -15.29%
10Years -19.61%
445 M FINANCING CASH FLOW
-48.76%
Growth Rates
1Year -48.76%
3Years -27.69%
5Years -3.39%
7Years 7.86%
10Years 15.71%
161 M REVENUE
4.15%
Growth Rates
1Year 14.81%
3Years 19.28%
5Years 26.91%
7Years 26.88%
10Years 27.69%
75.3 M OPERATING INCOME
1.20%
Growth Rates
1Year 18.81%
3Years 16.68%
5Years 24.49%
7Years 25.28%
10Years 26.91%
45.4 M NET INCOME
2.26%
Growth Rates
1Year 11.31%
3Years 15.60%
5Years 18.64%
7Years 18.23%
10Years 25.94%
91.4 M OPERATING CASH FLOW
-34.93%
Growth Rates
1Year 10.31%
3Years 20.59%
5Years 27.80%
7Years 26.75%
10Years 28.53%
-348 M INVESTING CASH FLOW
-41.13%
Growth Rates
1Year 30.56%
3Years 13.89%
5Years -5.81%
7Years -15.29%
10Years -19.61%
250 M FINANCING CASH FLOW
162.30%
Growth Rates
1Year -48.76%
3Years -27.69%
5Years -3.39%
7Years 7.86%
10Years 15.71%
Balance Sheet Agree Realty Corporation
image
Current Assets 113 M
Cash & Short-Term Investments 6.4 M
Receivables 106 M
Other Current Assets 0
Non-Current Assets 865 M
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 865 M
10.88 %88.46 %Total Assets$977.8m
Current Liabilities 2.28 B
Accounts Payable 116 M
Short-Term Debt 2.28 B
Other Current Liabilities -116 M
Non-Current Liabilities 696 M
Long-Term Debt 46.2 M
Other Non-Current Liabilities 650 M
3.91 %76.62 %21.83 %Total Liabilities$3.0b
EFFICIENCY
Earnings Waterfall Agree Realty Corporation
image
Revenue 617 M
Cost Of Revenue 74.8 M
Gross Profit 542 M
Operating Expenses 240 M
Operating Income 302 M
Other Expenses 112 M
Net Income 190 M
700m700m600m600m500m500m400m400m300m300m200m200m100m100m00617m(75m)542m(240m)302m(112m)190mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
87.87% GROSS MARGIN
87.87%
Averages
1Year 87.87%
3Years 85.66%
5Years 85.25%
7Years 86.03%
10Years 87.30%
48.98% OPERATING MARGIN
48.98%
Averages
1Year 48.98%
3Years 47.80%
5Years 49.21%
7Years 49.89%
10Years 51.64%
30.76% NET MARGIN
30.76%
Averages
1Year 30.76%
3Years 31.77%
5Years 33.14%
7Years 35.38%
10Years 40.26%
3.45% ROE
3.45%
Averages
1Year 3.45%
3Years 3.34%
5Years 3.44%
7Years 3.81%
10Years 4.83%
2.24% ROA
2.24%
Averages
1Year 2.24%
3Years 2.23%
5Years 2.28%
7Years 2.47%
10Years 3.01%
30.23% ROIC
30.23%
Averages
1Year 30.23%
3Years 12.24%
5Years 8.72%
7Years 7.30%
10Years 6.40%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Agree Realty Corporation
image
450m450m400m400m350m350m300m300m250m250m200m200m150m150m100m100m50m50m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 190 M
Depreciation & Amortization 240 M
Capital Expenditures 0
Stock-Based Compensation 10.8 M
Change in Working Capital -2.57 M
Others -11.1 M
Free Cash Flow 432 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Agree Realty Corporation
image
Wall Street analysts predict an average 1-year price target for ADC of $69 , with forecasts ranging from a low of $48 to a high of $81 .
ADC Lowest Price Target Wall Street Target
48 USD -32.75%
ADC Average Price Target Wall Street Target
69 USD -3.33%
ADC Highest Price Target Wall Street Target
81 USD 13.48%
Price
Max Price Target
Min Price Target
Average Price Target
858580807575707065656060555550504545May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
1.10% DIVIDEND YIELD
0.253 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
2.5002.5002.0002.0001.5001.5001.0001.0000.5000.5000.0000.0000.450.4650.4950.520.5550.5850.2070.2070.2070.2270.2270.2270.240.240.240.2470.2470.2470.2530.2530.2530.4650.480.5050.540.570.60.2170.2170.2170.2340.2340.2340.2430.2430.2430.250.250.250.4650.480.5050.540.570.60.2170.2170.2170.2340.2340.2340.2430.2430.2430.250.250.250.4651.850.4951.920.522.030.5551.620.5852.250.622.380.2271.250.2270.870.2270.870.240.920.240.940.240.940.2470.960.2470.970.2470.970.2530.990.2531.000.2531.000.500.250.252015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 12
6. Ownership
Insider Ownership Agree Realty Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
2.13 M USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
1.25 M USD 2
9-12 MONTHS
7. News
Mercy, Mercy, Mercy President Trump's tariff strategy is a high-stakes gamble that could either revive U.S. manufacturing or lead to inflation and economic retaliation. I believe the likelihood of a recession during Trump's term is now 100%, with JPMorgan raising the odds to 60% in the near term. Focus on high-quality, recession-resistant REITs like Healthpeak Properties, Terreno, Equity LifeStyle, and Agree Realty for stable returns amid market volatility. seekingalpha.com - 1 week ago
Need Dependable Passive Income Paid Monthly? Here Are Our 5 Favorite High-Yield Stocks Many dividend investors seek solid passive income from quality dividend stocks. 247wallst.com - 2 weeks ago
Agree Realty Announces First Quarter 2025 Earnings Release Date and Conference Call Information ROYAL OAK, Mich. , April 2, 2025 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that it will release its first quarter 2025 operating results after the market closes on Tuesday, April 22, 2025. prnewswire.com - 2 weeks ago
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan LAUSANNE, Switzerland , April 1, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made grants of options to purchase an aggregate of 128,600 of the Company's common shares to two new employees on April 1, 2025 (each, a "Grant"). The Grants were offered as material inducement to the employees' employment. prnewswire.com - 2 weeks ago
ADC Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference LAUSANNE, Switzerland , April 1, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will present a company overview at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 8:00 a.m. ET. A live webcast of the presentation will be available via the Events & Presentations page in the Investors section of ADC Therapeutics' website, ir.adctherapeutics.com. prnewswire.com - 2 weeks ago
4 Top Dividend Stocks Yielding Around 4% to Buy Without Hesitation in April Many companies have de-emphasized paying dividends over the years. That's one reason the dividend yield on the S&P 500 is only around 1.3% these days. fool.com - 2 weeks ago
Agree Realty Announces $625 Million Commercial Paper Program ROYAL OAK, Mich. , March 31, 2025 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced the establishment of its inaugural commercial paper program. prnewswire.com - 2 weeks ago
Why Agree Realty Is A Buy And Hold For Retirement Income New investors often aim to beat the market but should focus on downside protection, recession resiliency, and income for long-term success. Agree Realty offers stability with a strong balance sheet, high-quality tenants, and prudent portfolio management, making it a reliable investment. ADC's growth is supported by strategic acquisitions at attractive cap rates and disciplined capital allocation, justifying its premium valuation. seekingalpha.com - 3 weeks ago
Agree Realty: Is This Retail REIT Still A Buy After Sustained Rally? (Rating Downgrade) Agree Realty is paying out a 4% dividend yield, with AFFO guidance for its fiscal 2025 signalling healthy growth. There are no significant debt maturities until 2028 as ADC intends to invest at least $1.1 billion in net lease properties this year. The REIT's Series A preferreds offer a yield on cost that's 215 basis points greater than the commons, as the performance of both securities has diverged. seekingalpha.com - 3 weeks ago
ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update Initial data from LOTIS-7 Phase 1b trial of ZYNLONTA® plus glofitamab demonstrated clinically meaningful benefit with 94% best ORR and 72% CR rate; data update expected in second quarter 2025 Completed enrollment in LOTIS-5 Phase 3 confirmatory trial of ZYNLONTA plus rituximab in patients with 2L+ DLBCL; data update anticipated in late 2025 once PFS events reached $250.9M in cash as of December 31, 2024, provides runway expected to fund operations into the second half of 2026 Company to host conference call today at 8:30 a.m. EDT LAUSANNE, Switzerland , March 27, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today reported financial results for the fourth quarter and full year ended December 31, 2024, and provided recent operational updates. prnewswire.com - 3 weeks ago
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025 Oral presentation to highlight preclinical investigation of Claudin-6 ADC in ovarian and NSCLC cancer models Preclinical data for PSMA and ASCT2-targeted ADCs accepted for poster presentations LAUSANNE, Switzerland , March 25, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced abstracts detailing multiple preclinical programs have been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting 2025, taking place April 25-30, 2025, in Chicago, Illinois. "We are excited to present preclinical data on our exatecan-based Claudin-6, PSMA, and ACST2-targeting antibody-drug conjugates," said Patrick van Berkel, PhD, Chief Scientific Officer of ADC Therapeutics. prnewswire.com - 3 weeks ago
Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025 Expression data from patient-derived xenograft (PDX) mouse models exposed to micvotabart pelidotin (MICVO) indicate gene signatures associated with efficacy, deepening understanding of MOA and potential patient response globenewswire.com - 3 weeks ago
8. Profile Summary

Agree Realty Corporation ADC

image
COUNTRY US
INDUSTRY REIT - Retail
MARKET CAP $ 7.66 B
Dividend Yield 1.10%
Description Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.
Contact 70 East Long Lake Road, Bloomfield Hills, MI, 48304 https://www.agreerealty.com
IPO Date April 15, 1994
Employees 75
Officers Mr. Craig Erlich Chief Growth Officer Ms. Danielle M. Spehar J.D. General Counsel Mr. Reuben Goldman Treatman CPA Senior Director of Corporate Finance Mr. Joel N. Agree J.D. President, Chief Executive Officer & Director Mr. Larry Kaufman Chief Information Officer & Vice President of Continuous Improvement Mr. Peter Coughenour Chief Financial Officer, Secretary & Investor Relations Professional Ms. Nicole Witteveen Chief Operating Officer Mr. Josh Bratton Director of Development Mr. Richard A. Agree Executive Chairman of the Board Mr. Stephen Breslin Chief Accounting Officer